Filing Details
- Accession Number:
- 0001181431-14-003675
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-23 19:23:26
- Reporting Period:
- 2014-01-21
- Filing Date:
- 2014-01-23
- Accepted Time:
- 2014-01-23 19:23:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1011835 | Medivation Inc. | MDVN | Pharmaceutical Preparations (2834) | 133863260 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1568249 | J Jennifer Rhodes | C/O Medivation, Inc. 525 Market St., 36Th Floor San Francisco CA 94105 | Gc & Chief Compliance Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-01-21 | 14,000 | $47.48 | 20,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-01-21 | 9,400 | $76.05 | 10,600 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-01-21 | 4,300 | $76.66 | 6,300 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-01-21 | 100 | $77.44 | 6,200 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-01-21 | 100 | $78.14 | 6,100 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-01-21 | 100 | $78.83 | 6,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2014-01-21 | 14,000 | $0.00 | 14,000 | $47.48 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
42,000 | 2022-07-16 | No | 4 | M | Direct |
Footnotes
- Shares were sold pursuant to a 10b5-1 plan.
- The shares were sold at prices ranging from $75.41 to $76.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $76.41 to $77.36. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares subject to the option vest according to the following schedule: 25% of the shares subject to the option (rounded down to the next whole number of shares) vested on July 16, 2013, and 1/48th of the shares subject to the option (rounded down to the next whole number of shares) shall vest on the first day of each full month thereafter.